News

Following a routine audit, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) have restricted the manufacturing licence for five non-critical highly potent products…
Read More...

AbbVie announced that it will assume full development and commercial responsibility for its collaboration with Galapagos (Euronext: GLPG) to discover and develop new therapies to treat…
Read More...

AstraZeneca, and its global biologics research and development arm MedImmune, announced a new multi-term agreement with Innate Pharma (Innate), building on an existing collaboration,…
Read More...

Bain Capital, LP and Pfizer Inc. announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central…
Read More...

SGS announced that it is introducing new in vitro toxicology services at its Mississauga, Canada laboratory. The investment in instruments and expansion of the laboratory's…
Read More...

Two Labs announced it has acquired Pennside Partners Ltd., an international provider of market insights, benchmarking and competitive intelligence services for the pharmaceutical,…
Read More...

CANbridge Pharmaceutical and WuXi Biologics jointly announced a strategic partnership to enable CANbridge to develop and commercialize a portfolio of biotherapeutics for the treatment…
Read More...

Zymeworks and LEO Pharma have entered into a licensing and research collaboration to discover and develop bispecific antibodies targeting cytokine-receptor pathways using Zymeworks’…
Read More...

Mesoblast Limited announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for wound healing in patients with Epidermolysis Bullosa (EB). JCR has received…
Read More...

Velesco Pharma has expanded and enhanced its formulation and analytical research and development capabilities with the acquisition of a new facility in Wixom, Mich. The acquisition and…
Read More...

COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received Breakthrough Therapy designation from the…
Read More...

Almac Group announced that it has received a renewal of its GMP/GDP certification following the successful regulatory inspection by the Health Sciences Authority (HSA) of its facility…
Read More...

CASI Pharmaceuticals, Inc. announces that it has acquired a U.S. FDA-approved abbreviated new drug application (ANDA) from Laurus Labs Limited. The drug, tenofovir disoproxil fumarate…
Read More...

FSD Pharma Inc. announced the signing of a binding letter of intent (the “LOI”) to acquire Therapix Biosciences Ltd. effective October 22, 2018. The Transaction (the “Transaction”)…
Read More...

Purdue Pharma L.P. and SpineThera, Inc. announced that the companies have entered into an agreement that provides Purdue the exclusive option to acquire SpineThera, Inc. and gain…
Read More...

Orgenesis Inc. announced it has entered into a collaboration agreement with Hemogenyx Pharmaceuticals Plc (LSE: HEMO) to collaborate on the development and commercialization of…
Read More...

Vertex Pharmaceuticals (Europe) Limited announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for…
Read More...

LSK BioPharma and Jiangsu Hengrui Medicine announced that the companies have entered into a global clinical collaboration in patients with advanced hepatocellular carcinoma (HCC),…
Read More...

Pfizer Inc. announced detailed overall survival (OS) data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus…
Read More...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an…
Read More...